Abstract
Pink urine syndrome (PURS) is a rare and poorly documented complication that can occur during infusion of propofol, an intravenous anesthetic commonly used in general anesthesia and sedation. This phenomenon is characterized by abnormal pink or red coloration of the urine, often associated with an absence of severe clinical symptoms. Although its origin remains partially understood, it is suggested that the discoloration arises from the presence of propofol metabolites or drug degradation products. This article presents a clinical case illustrating this complication, outlining possible pathophysiological mechanisms, risk factors, as well as clinical management and implications for anesthetic practice.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have